| Item Type | Name |
|
Concept
|
Japanese Encephalitis Vaccines
|
|
Concept
|
Vaccines, Inactivated
|
|
Concept
|
Viral Vaccines
|
|
Concept
|
Vaccines, Combined
|
|
Concept
|
Haemophilus Vaccines
|
|
Concept
|
Rotavirus Vaccines
|
|
Concept
|
Salmonella Vaccines
|
|
Concept
|
Cholera Vaccines
|
|
Concept
|
Escherichia coli Vaccines
|
|
Concept
|
Vaccines, Conjugate
|
|
Concept
|
Vaccines, Attenuated
|
|
Concept
|
Typhoid-Paratyphoid Vaccines
|
|
Concept
|
Bacterial Vaccines
|
|
Concept
|
Shigella Vaccines
|
|
Concept
|
Vaccines, Subunit
|
|
Academic Article
|
Efficacy of a Single-Dose, Inactivated Oral Cholera Vaccine in Bangladesh.
|
|
Academic Article
|
An Open Label Non-inferiority Trial Assessing Vibriocidal Response of a Killed Bivalent Oral Cholera Vaccine Regimen following a Five Year Interval in Kolkata, India.
|
|
Academic Article
|
Evaluation of the safety and immunogenicity of the oral inactivated multivalent enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi adults in a double-blind, randomized, placebo-controlled Phase I trial using electrochemiluminescence and ELISA assays for immunogenicity analyses.
|
|
Academic Article
|
Desirability for a typhoid fever vaccine among rural residents, Pemba Island, Tanzania.
|
|
Academic Article
|
Assessing different measures of population-level vaccine protection using a case-control study.
|
|
Academic Article
|
Flexibility of oral cholera vaccine dosing-a randomized controlled trial measuring immune responses following alternative vaccination schedules in a cholera hyper-endemic zone.
|
|
Academic Article
|
Effectiveness of an oral cholera vaccine campaign to prevent clinically-significant cholera in Odisha State, India.
|
|
Academic Article
|
Vaccines Against Shigella and Enterotoxigenic Escherichia coli: A summary of the 2018 VASE Conference.
|
|
Academic Article
|
5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial.
|
|
Academic Article
|
The global burden of enteric fevers in the age of typhoid-conjugate vaccines.
|
|
Academic Article
|
Herd protection by a bivalent killed whole-cell oral cholera vaccine in the slums of Kolkata, India.
|
|
Academic Article
|
Risk map of cholera infection for vaccine deployment: the eastern Kolkata case.
|
|
Academic Article
|
Laboratory-based Japanese encephalitis surveillance in Nepal and the implications for a national immunization strategy.
|
|
Academic Article
|
Development of pathogenicity-driven definitions of outcomes for a field trial of a killed oral vaccine against enterotoxigenic Escherichia coli in Egypt: application of an evidence-based method.
|
|
Academic Article
|
Burden of typhoid fever in low-income and middle-income countries: a systematic, literature-based update with risk-factor adjustment.
|
|
Academic Article
|
Efficacy of a single-dose regimen of inactivated whole-cell oral cholera vaccine: results from 2 years of follow-up of a randomised trial.
|
|
Academic Article
|
An Estimation of Private Household Costs to Receive Free Oral Cholera Vaccine in Odisha, India.
|
|
Academic Article
|
25 years after Vi typhoid vaccine efficacy study, typhoid affects significant number of population in Nepal.
|
|
Academic Article
|
Enteric vaccines for resource-limited countries: current status and future prospects.
|
|
Academic Article
|
Validity of the estimates of oral cholera vaccine effectiveness derived from the test-negative design.
|
|
Academic Article
|
Increasing rates of Salmonella Paratyphi A and the current status of its vaccine development.
|
|
Academic Article
|
Uptake during an oral cholera vaccine pilot demonstration program, Odisha, India.
|
|
Academic Article
|
Vaccines against Shigella and enterotoxigenic Escherichia coli: A summary of the 2016 VASE Conference.
|
|
Academic Article
|
Implications and measurement of herd protection (indirect effects) for enteric vaccine development.
|
|
Academic Article
|
Vaccine introduction in the Democratic People's Republic of Korea.
|
|
Academic Article
|
Effectiveness of the Viet Nam produced, mouse brain-derived, inactivated Japanese encephalitis vaccine in Northern Viet Nam.
|
|
Academic Article
|
Defining cases of severe pediatric diarrhea for an efficacy trial of an enterotoxigenic Escherichia coli (ETEC) vaccine: Report on an international workshop, Washington DC, March 2016.
|
|
Academic Article
|
Oral cholera vaccines and their impact on the global burden of disease.
|
|
Academic Article
|
Status of vaccine research and development for Shigella.
|
|
Academic Article
|
Strategy, demand, management, and costs of an international cholera vaccine stockpile.
|
|
Academic Article
|
Status of vaccine research and development for enterotoxigenic Escherichia coli.
|
|
Academic Article
|
Determining the Best Immunization Strategy for Protecting African Children Against Invasive Salmonella Disease.
|
|
Academic Article
|
A Randomized, Placebo-Controlled Trial Evaluating Safety and Immunogenicity of the Killed, Bivalent, Whole-Cell Oral Cholera Vaccine in Ethiopia.
|
|
Academic Article
|
Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study.
|
|
Academic Article
|
A phase I trial of WRSS1, a Shigella sonnei live oral vaccine in Bangladeshi adults and children.
|
|
Academic Article
|
Mass vaccination with a new, less expensive oral cholera vaccine using public health infrastructure in India: the Odisha model.
|
|
Academic Article
|
Potential impact and cost-effectiveness of future ETEC and Shigella vaccines in 79 low- and lower middle-income countries.
|
|
Academic Article
|
Introductory evaluation of an oral, killed whole cell enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Egyptian infants.
|
|
Academic Article
|
Whom and where are we not vaccinating? Coverage after the introduction of a new conjugate vaccine against group A meningococcus in Niger in 2010.
|
|
Academic Article
|
Impact of oral cholera vaccines in cholera-endemic countries: A mathematical modeling study.
|